Viridian Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:VRDN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Sep 24	BuyUS$499,262	Stephen Mahoney	Individual	21,400	US$23.33
27 Sep 24	BuyUS$117,050	Thomas Beetham	Individual	5,000	US$23.41
13 Sep 24	BuyUS$30,000,000	Fairmount Funds Management LLC	Company	1,600,000	US$18.75
22 Jan 24	BuyUS$9,999,990	Fairmount Funds Management LLC	Company	476,190	US$21.00

Insider Trading Volume

Insider Buying: VRDN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VRDN?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	62,474	0.074%
Institutions	84,342,704	99.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 50.6%.

Top Shareholders

Top 25 shareholders own 80.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.1%	FMR LLC	11,183,478	US$212.8m	16.8%	0.01%
6.06%	BlackRock, Inc.	4,804,006	US$91.4m	0.64%	no data
5.58%	The Vanguard Group, Inc.	4,420,097	US$84.1m	32.1%	no data
4.74%	Deep Track Capital, LP	3,750,945	US$71.4m	-4.41%	2.23%
4.35%	Fairmount Funds Management LLC	3,445,813	US$65.6m	86.7%	5.3%
3.66%	Paradigm Biocapital Advisors LP	2,895,689	US$55.1m	-0.02%	2.02%
3.55%	Perceptive Advisors LLC	2,812,665	US$53.5m	72.4%	1.25%
3.22%	Commodore Capital LP	2,550,124	US$48.5m	0.87%	3.34%
3.17%	Kynam Capital Management, LP	2,511,295	US$47.8m	43.5%	3.85%
3.01%	Novo Holdings A/S	2,385,000	US$45.4m	19.3%	0.03%
3%	State Street Global Advisors, Inc.	2,379,774	US$45.3m	-14.2%	no data
2.83%	Tang Capital Management, LLC	2,242,925	US$42.7m	61%	3.15%
2.78%	AllianceBernstein L.P.	2,202,739	US$41.9m	10.2%	0.01%
2.52%	Maverick Capital, Ltd.	1,997,153	US$38.0m	-39.6%	0.69%
2.51%	Driehaus Capital Management LLC	1,991,490	US$37.9m	2,270%	0.23%
2.47%	EcoR1 Capital, LLC	1,958,847	US$37.3m	0%	1.28%
2.12%	Vivo Capital, LLC	1,678,207	US$31.9m	0%	2.72%
1.89%	Geode Capital Management, LLC	1,493,311	US$28.4m	5.81%	no data
1.71%	VR Adviser, LLC	1,352,322	US$25.7m	-65.2%	1.32%
1.52%	Adage Capital Management, L.P.	1,205,000	US$22.9m	0%	0.04%
1.29%	Pictet Asset Management Limited	1,025,337	US$19.5m	0.32%	0.02%
1.22%	Morgan Stanley, Investment Banking and Brokerage Investments	968,485	US$18.4m	219%	no data
1.1%	Octagon Capital Advisors LP	870,000	US$16.6m	40.3%	2.69%
1.07%	Yiheng Capital Management, L.P.	847,891	US$16.1m	-10.6%	2.96%
1.03%	Woodline Partners LP	818,995	US$15.6m	104%	0.14%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:13
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Viridian Therapeutics, Inc. is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Madhu Kumar	Baird
Madhu Kumar	B. Riley Securities, Inc.
Kalpit Patel	B. Riley Securities, Inc.